786 Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics A Study Section. 

Date: February 7–8, 2019. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9448, shinako.takada@

nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 25, 2019. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00328 Filed 1–30–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Molecular 

and Cellular Endocrinology Study Section. 

Date: February 7, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: San Diego Marriott Mission Valley, 

8757 Rio San Diego Drive, San Diego, CA 

92108. 

Contact Person: Elaine Sierra-Rivera, Ph.D., 

Scientific Review Officer, EMNR IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6182, 

MSC 7892, Bethesda, MD 20892, 301 435– 

2514, riverase@csr.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 24, 2019. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00363 Filed 1–30–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Fellowships in 

Diabetes, Endocrinology and Metabolic 

Diseases. 

Date: February 12–13, 2019. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Thomas A. Tatham, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7021, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–3993, 

tathamt@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 25, 2019. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00349 Filed 1–30–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Statistical Analysis in Late Phase Clinical 

Trial Design. 

Date: February 15, 2019. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Baltimore Washington 

Airport Hotel, 1100 Old Elkridge Landing 

Road, Linthicum Heights, MD 21090. 

Contact Person: David A. Wilson, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6701 

Rockledge Drive, Room 7204, Bethesda, MD 

20892, 301–827–7953, wilsond@

nhlbi.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government Shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices 787 

Dated: January 25, 2019. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00323 Filed 1–30–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cell Biology 

Integrated Review Group; Molecular and 

Integrative Signal Transduction Study 

Section. 

Date: February 7–8, 2019. 

Time: 8:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Torrance Marriott Redondo Beach, 

3635 Fashion Way, Torrance, Torrance, CA 

90503. 

Contact Person: Charles Selden, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5187, 

MSC 7840, Bethesda, MD 20892, 301–451– 

3388, seldens@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 25, 2019. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00330 Filed 1–30–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Treatment Episode Data Set 

(TEDS) (OMB No. 0930–0335)— 

Extension 

The Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) is requesting an extension to 

collect the Treatment Episode Data Set 

(TEDS) data collection (OMB No. 0930– 

0335), which expires on March 31, 

2019. TEDS is a compilation of clientlevel substance use treatment admission 

and discharge data submitted by states 

on clients treated in facilities that 

receive state funds. SAMHSA is also 

requesting an extension to collect the 

client-level mental health admission 

and update/discharge data (MH–TEDS/ 

MH–CLD) submitted by states on clients 

treated in facilities that receive state 

funds (also OMB No. 0930–0335). 

TEDS/MH–TEDS/MH–CLD data are 

collected to obtain information on the 

number of admissions and updates/ 

discharges at publicly funded substance 

use treatment and mental health 

services facilities and on the 

characteristics of clients receiving 

services at those facilities. 

TEDS/MH–TEDS/MH–CLD also 

monitor trends in the demographic, 

substance use, and mental health 

characteristics of admissions. In 

addition, several of the data elements 

used to calculate performance measures 

for the Substance Abuse Block Grant 

(SABG) and Mental Health Block Grant 

(MHBG) applications are collected 

through the TEDS/MH–TEDS/MH–CLD. 

Most states collect the TEDS/MH– 

TEDS/MH–CLD data elements from 

their treatment providers for their own 

administrative purposes and are able to 

submit a cross-walked extract of their 

data to TEDS/MH–TEDS/MH–CLD. No 

changes are expected in the TEDS/MH– 

TEDS/MH–CLD data elements that are 

collected. 

Estimated annual burden for the 

separate TEDS/MH–TEDS/MH–CLD 

activities is as follows: 

Type of activity 

Number of 

respondents 

(states/ 

jurisdictions) 

Responses per 

respondent 

Total 

responses 

Hours 

per response 

Total burden 

hours 

TEDS Admission Data ....................................................... 52 4 208 6.25 1,300 

TEDS Discharge Data ....................................................... 52 4 208 8.25 1,716 

TEDS Crosswalks .............................................................. 5 1 5 10 50 

MH–CLD BCI Data ............................................................ 30 1 30 30 900 

MH–CLD SHR Data ........................................................... 30 1 30 5 150 

MH–TEDS Admissions Data .............................................. 29 4 116 6.25 725 

MH–TEDS Update/Discharge Data ................................... 29 4 116 8.25 957 

MH–TEDS Crosswalks ...................................................... 10 1 10 10 100 

Total ............................................................................ 59 .......................... 723 ........................ 5,898 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by March 4, 2019 to the 

SAMHSA Desk Officer at the Office of 

Information and Regulatory Affairs, 

Office of Management and Budget 

(OMB). To ensure timely receipt of 

comments, and to avoid potential delays 

in OMB’s receipt and processing of mail 

sent through the U.S. Postal Service, 

commenters are encouraged to submit 

their comments to OMB via email to: 

OIRA_Submission@omb.eop.gov. 

Although commenters are encouraged to 

send their comments via email, 

commenters may also fax their 

comments to: 202–395–7285. 


amozie on DSK3GDR082PROD with NOTICES1